OQROGet OQRO Pro
Insider trade

Dyne Therapeutics (DYN)Officer sold ~$41K

Richard William Scalzo, Officer at Dyne Therapeutics, sold ~$41K of Dyne Therapeutics shares.

~$41K
Approx. value · 1,455 sh @ $28.12
127K
Holds after · shares reported
Traded
Dec 11, 2024
Filed
Dec 12, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 16, 2024InsiderDirector sold ~$837K of DYN shares in the open market
  2. Oct 17, 2024InsiderDirector sold ~$458K of DYN shares in the open market
  3. Oct 18, 2024InsiderDirector sold ~$472K of DYN shares in the open market
  4. Oct 21, 2024InsiderDirector sold ~$4.2K of DYN shares in the open market
  5. Nov 13, 2024InsiderDirector sold ~$381K of DYN shares in the open market
  6. Nov 14, 2024Insider · 2 peopleInsiders: 5 sales (~$319K)
  7. Nov 18, 2024Insider · 3 peopleInsiders: 3 sales (~$632K)
  8. Dec 2, 2024Insider · 1 personInsiders: 2 sales (~$2.4M)
  9. Dec 3, 2024InsiderDirector sold ~$864K of DYN shares in the open market
  10. Dec 4, 2024InsiderDirector sold ~$3.97M of DYN shares in the open market
  11. Dec 5, 2024InsiderDirector sold ~$111K of DYN shares in the open market
  12. Dec 6, 2024InsiderDirector sold ~$2.98M of DYN shares in the open market
  13. Dec 9, 2024InsiderDirector sold ~$1M of DYN shares in the open market
  14. Dec 11, 2024 · this disclosureInsiderOfficer sold ~$41K of DYN shares in the open market

What came next

  1. Dec 11, 2024InsiderOfficer sold ~$66K of DYN shares in the open market
  2. Feb 18, 2025Insider · 2 peopleInsiders: 2 sales (~$71K)
  3. Mar 5, 2025Insider · 4 peopleInsiders: 4 sales (~$88K)
  4. Mar 11, 2025Insider · 2 peopleInsiders: 2 sales (~$40K)
  5. Mar 13, 2025InsiderOfficer sold ~$1.7K of DYN shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Dyne Therapeutics

For Dyne Therapeutics, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 6 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DYN page.

Other recent filings by Richard William Scalzo, SVP, Head of Finance & Admin.

The full history of Richard William Scalzo, SVP, Head of Finance & Admin. is on the profile page.

How this filing works

Other disclosures at Dyne Therapeutics

Everything OQRO holds on this company is on its DYN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data